Skip to main content
OpenTrials
Completed

NCT Number: NCT04055662

A Comparison of Post-Operative Analgesia Requirements In Recreational Cannabis Users Versus Cannabis Naïve Inflammatory Bowel Disease Patients

Cannabis is a drug that is widely used for recreational purpose. In most patients undergoing surgery, opioids are the most widely used mode of pain relief, during and following surgery. Anecdotally it has been observed that cannabis users required unexpectedly high doses of opioids. The purpose of this study is to compare opioid requirements between cannabis users and non- users after the surgery. Currently, post-operative opioid doses are determined based on various patient factors such as pre-operative opioid use, patient weight, age and sensitivity to opioids during surgery. Patients' requirements may be underestimated and opioid regimens need to be escalated in the first 24 hours in order to alleviate uncontrolled pain in cannabis users. Better understanding of the impacts of cannabis use on post-operative opioid requirements would help the Acute Pain Service optimize post-operative pain management for patients who use cannabis pre-operatively.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sinai Health System

Toronto, Ontario, M5G1X2, Canada

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Consent to participate and signed consent form.
  • Age: 18-65 years.
  • Elective IBD bowel surgery under general anesthesia.
  • PCA use.

Treatment and study plan

Primary outcomes

  1. Opioid consumption

    Time frame: 2 years

    Amount of morphine equivalents on PCA

Sponsors and collaborators

Lead sponsor

Mount Sinai Hospital, Canada

Other

Registry information

Official study title

A Comparison of Post-Operative Analgesia Requirements In Recreational Cannabis Users

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Aug 14, 2019
Registry last updated
Apr 11, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.